Statins do not reduce atrial fibrillation after cardiac valvular surgery: A single centre observational study

Netherlands Heart Journal

Volumn 19, Issue 1, 2011, Pages 17-23

  Folkeringa, R J ^a   Tieleman, R G ^b   Maessen, J G ^c   Prins, M H ^c   Nieuwlaat, R ^d   Crijns, H J G M ^c  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Atrial fibrillation; Cardiac surgery; Statin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG TREATMENT FAILURE; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE;

EID: 79955399030     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-010-0055-3     Document Type: Article

References (23)

1. Bonow RO, Carabello B Jr, et al. ACC/AHH guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee on management of patients with valvular heart disease). Circulation. 1998;98:1949-84.
2. Heart Protection Study Collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
3. Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid lowering arm (ASCOTT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-58.
4. Ridker PM, Rifai N, Clearfeld M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959-65.
5. Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertro-phic cardiomyopathy. Circulation. 2001;104:317-24.
6. Su SF, Hsiao CL, Chu CW, Lee BC, Lee TM. Effects of pravastatin on left ventricular mass in patients with hyperlip-idemia and essential hypertension. Am J Cardiol. 2000;86:514-518.
7. Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiotensin-II induced cardiac hypertrophy in cultured neonatal rat heart cells. Eur J Pharmacol. 1999;376:139-48.
8. Indolfi C, Di Lorenzo E, Perrino C, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation. 2002;106:2118-2124.
9. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation. 2006;114:1455-1461.
10. Dotani MI, Elnicki M, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000;86:1128-1130.
11. Fauchier L, Pierre B, De Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation. A meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51:828-35.
12. Ozaydin M, Gogan A, Varol E, et al. Statin use before bypass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007;107:117-121.
13. Marin F, Pascual DA, Roldan V, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97:55-60.
14. Mariscalco G, Lorusso R, Klersy C, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007;84:1158-1165.
15. Amar D, Zhang H, Heerdt PM, et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest. 2005;128:3421-3427.
16. Virani SS, Nambi V, Razavi M, et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008;155:541-546.
17. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the manage- ment of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425-1433.
18. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399-1402.
19. Gaudino M, Andreotti F, Zamparelli R, et al. The-174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003;108 SUPPL I:ii195-199.
20. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.
21. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-4.
22. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:793-801.
23. Isaac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation. J Am Coll Cardiol. 2007;50:2021-8.